MFDS
- Status: likely_approved
🇰🇷 Crysvita in South Korea
Crysvita (BUROSUMAB) regulatory status in South Korea.
Marketing authorisation
Crysvita in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in South Korea
Frequently asked questions
Is Crysvita approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Crysvita in South Korea?
Ultragenyx Pharm Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.